跳至主要内容
临床试验/NCT01580527
NCT01580527Unknown不适用

A Prospective, Multicentric, Randomized Trial Comparing Early Enteral Nutrition Versus Parenteral Nutrition After Pancreaticoduodenectomy

Hospices Civils de Lyon2 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2011年3月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
220
试验地点
2
主要终点
Percentage of patients presenting one or several postoperative complications

研究概览

简要总结

Pancreaticoduodenectomy is a major surgery burdened by important morbidity and mortality partially related to the altered nutritional status of the patients. The perioperative malnutrition is a major risk factor of postoperative complications and worsens the prognosis of the patients. The perioperative artificial nutrition has for objectives to correct the preoperative malnutrition, and to maintain the nutritional status in the post-operative period. The current guidelines in surgery are in favour of a realisation of a perioperative artificial nutrition support that privilege the enteral nutrition. However, after pancreaticoduodenectomy, the total parenteral nutrition remains most usually used in the early postoperative period, although rare studies suggest a benefit of the enteral nutrition in term of reduction of the post-operative complications. Indeed, no recommendation was formulated concerning early enteral nutrition after pancreaticoduodenectomy because few studies were realized on its profits.

The data of the literature report rates of complications (essentially major) from 49 % to 59 % after major digestive surgery (not only pancreatic) on patients having received a total parenteral nutrition versus rates from 34 to 43.8 % in patients having received an early enteral nutrition.

A preliminary prospective study realized in the investigators centre showed a rate of 74 % complication versus 44 %, respectively in the total parenteral nutrition and early enteral nutrition groups (50 patients in every group, with p < 0.01. All the complications were listed prospectively).

Hypothesis :

The early enteral nutrition will allow, after pancreaticoduodenectomy, a decrease of, at least, 19 % complications of any stage according to the classification of Dindo-Clavien (59 % versus 40 %).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patients more than 18 years of age.
  • Pancreatic surgery by pancreaticoduodenectomy.
  • Patient affiliated to a mode of the social security or receiving of such a mode.
  • Having given written informed consent prior to any procedure related to the study

排除标准

  • ASA score ≥4
  • Pregnant women
  • Patient who cannot give written informed consent.
  • Concomitant participation in a biomedical study being able to interfere with this research
  • Patient less than 18 years of age or more than 18 years of age, protected by the Law, under guardianship

研究组 & 干预措施

Early enteral nutrition

Experimental

干预措施: Enteral nutrition (Procedure)

结局指标

主要结局

Percentage of patients presenting one or several postoperative complications

时间窗: 90 days

Data recorded during the period of hospitalization (an expected average of 3 weeks) and until control visit 3 months after surgery

次要结局

  • Pancreatic fistulas(within the hospitalization time after the surgery (an expected average of 3 weeks))
  • Nutritional status(90 days)
  • gastroparesis(within the hospitalization time after the surgery (an expected average of 3 weeks))
  • Time frame of resumption of the intestinal bowel motion(within the hospitalization time after the surgery (an expected average of 3 weeks))
  • Infectious complications(within the hospitalization time after surgery (an expected average of 3 weeks))
  • Evaluation of the severity of the complications(within the hospitalization time after the surgery (an expected average of 3 weeks))
  • Hemorrhagic complications(within the hospitalization time after the surgery (an expected average of 3 weeks))
  • Duration of hospital stay(within the hospitalization time after the surgery (an expected average of 3 weeks))
  • Time frame of resumption of the oral food and artificial nutrition weaning(within the hospitalization time after the surgery (an expected average of 3 weeks))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验